F542-0901 Screening compound: 6-[5-(1-ethyl-1H-pyrazol-3-yl)-1,2,4-oxadiazol-3-yl]-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

F542-0901 Screening compound: 6-[5-(1-ethyl-1H-pyrazol-3-yl)-1,2,4-oxadiazol-3-yl]-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione
F542-0901 Screening compound: 6-[5-(1-ethyl-1H-pyrazol-3-yl)-1,2,4-oxadiazol-3-yl]-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound F542-0901
6-[5-(1-ethyl-1H-pyrazol-3-yl)-1,2,4-oxadiazol-3-yl]-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F542-0901

Molecular Formula

C19H20N6O3 (C19 H20 N6 O3)

Compound Name

6-[5-(1-ethyl-1H-pyrazol-3-yl)-1,2,4-oxadiazol-3-yl]-1-(2-methylpropyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

IUPAC name

6-[5-(1-ethyl-1H-pyrazol-3-yl)-124-oxadiazol-3-yl]-1-(2-methylpropyl)-1234-tetrahydroquinoxaline-23-dione

SMILES

CCn(cc1)nc1-c1nc(-c(cc2)cc(NC3=O)c2N(CC(C)C)C3=O)no1

InChI

InChI=1S/C19H20N6O3/c1-4-24-8-7-13(22-24)18-21-16(23-28-18)12-5-6-15-14(9-12)20-17(26)19(27)25(15)10-11(2)3/h5-9,11H,4,10H2,1-3H3,(H,20,26)

InChI Key

GMELUKNMRZNSEH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27175028

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

380.41

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.008

Distribution Coefficient, logD

2.989

Water Solubility, LogSw

-3.41

Polar Surface Area

86.360

Acid Dissociation Constant (pKa)

8.75

Base Dissociation Constant (pKb)

-0.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.60

F542-0901 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

BRD4 Targeted Library (4534 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
Targets:
  • Others

References: we are preparing a list of scientific research reports with F542-0901 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F542-0901?
Check Price and Availability of F542-0901, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F542-0901 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F542-0901
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F542-0901
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F542-0901 available by request